The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored b...
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024
Project: PET3D
Updated at: 28-04-2024